Yesterday we witnessed the end of era when Johnson and Johnson (NYSE: JNJ) released fourth quarter and full year results. Today we witnessed a reemergence of a once dead company when Abbott (NYSE: ABT) released fourth quarter and full year results. The short story here is that Abbott adapted to change while JNJ didn’t. Yes, we know its more complex than that, but Abbott read the tea leaves better than JNJ. Abbott saw the future was CGM, invested heavily and hence is now the leader in CGM.
Let’s take a quick look at the results per the company . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.